Sponsor
Oncusp Therapeutics Inc.
433 Broadway, 10013-2510, United States
About the sponsor
Clinical research at Oncusp Therapeutics Inc. is centered on solid tumours with a strong focus on advanced and treatment-resistant disease settings, including platinum-resistant ovarian cancer and broader advanced solid tumours.
- Platinum-resistant ovarian cancer
- Platinum-refractory ovarian cancer
- Advanced solid tumours
The sponsor’s oncology portfolio reflects interest in cancers that remain difficult to treat after standard therapy, with attention to tumour types requiring new targeted options.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.